Drug Profile
RO 452082
Latest Information Update: 28 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 04 Aug 1998 No-Development-Reported for Septic shock in USA (Unknown route)
- 14 May 1996 New profile
- 14 May 1996 Preclinical development for Septic shock in USA (Unknown route)